您的位置: 首页 > 农业专利 > 详情页

method of treating and / or preventing drea or asthma in human patients; and method of prevention, reversal or treatment of aspirin desensitization symptom (s) in patients with drea
专利权人:
CUMBERLAND PHARMACEUTICALS; INC.
发明人:
LEO PAVLIV
申请号:
BR112017027298
公开号:
BR112017027298A2
申请日:
2016.06.28
申请国别(地区):
BR
年份:
2018
代理人:
摘要:
The present invention is directed to methods of treating drea (aspirin-exacerbated respiratory disease) and / or asthma by administering a thromboxane receptor antagonist to a patient in need thereof.a presente invenção é direcionada a métodos de tratamento de drea (doença respiratória exacerbada por aspirina) e/ou asma por meio da administração de um antagonista de receptor de tromboxano a um paciente que precisa dele.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充